These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 15118874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
    [Abstract] [Full Text] [Related]

  • 3. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 4. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H, Kleihues P.
    J Neuropathol Exp Neurol; 2005 Jun 01; 64(6):479-89. PubMed ID: 15977639
    [Abstract] [Full Text] [Related]

  • 5. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 Jun 01; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nistér M, Smits A, Ren ZP.
    Acta Neuropathol; 2007 Feb 01; 113(2):129-36. PubMed ID: 17031656
    [Abstract] [Full Text] [Related]

  • 8. Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.
    Thon N, Eigenbrod S, Grasbon-Frodl EM, Ruiter M, Mehrkens JH, Kreth S, Tonn JC, Kretzschmar HA, Kreth FW.
    J Neuropathol Exp Neurol; 2009 Nov 01; 68(11):1219-28. PubMed ID: 19816195
    [Abstract] [Full Text] [Related]

  • 9. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 01; 33(10):752-8. PubMed ID: 22335907
    [Abstract] [Full Text] [Related]

  • 10. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
    Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K.
    Cancer; 2003 May 01; 97(9):2254-61. PubMed ID: 12712480
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 12. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
    Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB.
    Genes Chromosomes Cancer; 2005 Jan 01; 42(1):68-77. PubMed ID: 15472895
    [Abstract] [Full Text] [Related]

  • 13. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR.
    Chin Med J (Engl); 2010 Dec 01; 123(24):3566-73. PubMed ID: 22166632
    [Abstract] [Full Text] [Related]

  • 14. Gene expression profiling and subgroup identification of oligodendrogliomas.
    Huang H, Okamoto Y, Yokoo H, Heppner FL, Vital A, Fevre-Montange M, Jouvet A, Yonekawa Y, Lazaridis EN, Kleihues P, Ohgaki H.
    Oncogene; 2004 Aug 05; 23(35):6012-22. PubMed ID: 15208679
    [Abstract] [Full Text] [Related]

  • 15. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 05; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
    Yang P, Kollmeyer TM, Buckner K, Bamlet W, Ballman KV, Jenkins RB.
    Cancer; 2005 Jun 01; 103(11):2363-72. PubMed ID: 15834925
    [Abstract] [Full Text] [Related]

  • 17. Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status.
    Fathi AR, Vassella E, Arnold M, Curschmann J, Reinert M, Vajtai I, Weis J, Deiana G, Mariani L.
    Strahlenther Onkol; 2007 Sep 01; 183(9):517-22. PubMed ID: 17762927
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A.
    J Neuropathol Exp Neurol; 1997 Oct 01; 56(10):1098-104. PubMed ID: 9329453
    [Abstract] [Full Text] [Related]

  • 19. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
    Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB.
    J Clin Oncol; 2000 Feb 01; 18(3):636-45. PubMed ID: 10653879
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.
    Clin Neuropathol; 2006 Feb 01; 25(1):18-24. PubMed ID: 16465770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.